As both MCF-7 and MDA-MB 231 cancer cell lines have been shown to express different COX isoenzymes [32], we expected that blocking endogenous PGE2 by COX inhibitors would increase CXCR3 ligand secretion. Here, CXCR3 is linked to cancer.